Clinical Trial Update: Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is ongoing to evaluate the safety and efficacy of PA9159 inhalation aerosol for adult bronchial asthma, with recruitment currently ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PA9159 inhalation aerosol (PA9159)

Snippet

Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. | Conditions: Bronchial Asthma | Phase 2 | Status: RECRUITING